(Q36047240)

11 August 2017

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo (English)

1 reference

11 August 2017

0 references

Overgaard J

1

1 reference

11 August 2017

Overgaard M

2

1 reference

11 August 2017

Nielsen OS

3

1 reference

11 August 2017

Pedersen AK

4

1 reference

11 August 2017

Timothy AR

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 1982

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

46

1 reference

11 August 2017

6

1 reference

11 August 2017

904-911

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1982.300

11 August 2017

0 references

cites work

Pharmacokinetics of hypoxic cell radiosensitizers: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Prolonged metronidazole administration with protracted radiotherapy: a pilot study on response of advanced tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Misonidazole—A drug for trial in radiotherapy and oncology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

A drug for improved radiosensitization in radiotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Studies on antiprotozoans. 3. Isolation, identification and quantitative determination in humans of the metabolites of a new trichomonacidal agent

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Nitroimidazole neurotoxicity: are mouse studies predictive?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Final report on the united states phase i clinical trial of the hypoxic cell radiosensitizer, misonidazole (RO-07-0582; NSC #261037)

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Clinical experience with misonidazole: high dose fractions versus daily low doses

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011219

Radiosensitizers of hypoxic cells in solid tumors

23 September 2018

1 reference

12 December 2020

The radiosensitizing effect of metronidazole and misonidazole (Ro–07–0582) on a human malignant melanoma grown in the athymic mutant nude mouse

1 reference

12 December 2020

Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole

1 reference

12 December 2020

Analysis of the basic 5-nitroimidazole nimorazole in blood by reversed-phase high-performance liquid chromatography, and its application to pharmacokinetic studies in individual mice

1 reference

12 December 2020

Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo

1 reference

12 December 2020

Structure-pharmacokinetic relationships for misonidazole analogues in mice

1 reference

12 December 2020

The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: An rtog pilot study (#78-02)

1 reference

12 December 2020

Clinical experience with nitroimidazoles as radiosensitizers

1 reference

12 December 2020

Initial pharmacology and toxicology of intravenous desmethylmisonidazole

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1982.300

1 reference

11 August 2017

1 reference

11 August 2017

1 reference